title: Effect of HIV and chlamydia infection on rectal inflammation and cytokine concentrations in men who have sex with men.
abstract: Asymptomatic Chlamydia trachomatis infections are common in HIV-infected men who have sex with men (MSM). Although C. trachomatis combined with HIV would be likely to enhance inflammation, the asymptomatic course suggests otherwise. We assessed local inflammation, mucosal damage, and cytokine concentrations in rectal mucosal fluid samples from patients with HIV (with or without the use of combination antiretroviral therapy [cART]) and with or without the presence of rectal C. trachomatis. Rectal swabs from 79 MSM (with and without C. trachomatis, HIV, and cART use) who reported a history of receptive anal sex were analyzed for neutrophil activation (measured by myeloperoxidase [MPO]), mucosal leakage (measured by albumin and alpha-2-macroglobulin), and proinflammatory and anti-inflammatory cytokines. C. trachomatis infection, HIV infection, and cART use in MSM had no differential effects on rectal neutrophilic inflammation and mucosal damage. Interleukin 8 (IL-8) was found to correlate with MPO, and MPO correlated with markers of mucosal damage. In HIV-negative participants, men with C. trachomatis infection had lower concentrations of monocyte chemotactic protein 1 (MCP-1), IL-1α, and IL-1 receptor antagonist (IL-1RA) than men without rectal C. trachomatis infection (P = 0.005, 0.007, and 0.07, respectively). We found no difference in anal cytokine concentrations in HIV-infected participants in relation to the presence of C. trachomatis infection or cART use. In participants with rectal C. trachomatis infection, those who were HIV negative had lower median concentrations of IL-8 and IL-1α than those with HIV (P = 0.05 and 0.06, respectively). The slope of the regression line between MPO and IL-8 was reduced in participants with rectal C. trachomatis infection. C. trachomatis dampens cytokine concentrations but not in HIV-infected patients. The extent of mucosal damage was comparable in all patient groups. The apparent reduced neutrophil response to IL-8 in HIV-infected patients with C. trachomatis infection is in accordance with its asymptomatic course.
authors.affiliation: Cluster of Infectious Diseases, Health Service Amsterdam, Amsterdam, the Netherlands.
authors.forename: Marlies
authors.initials: M
authors.lastname: Heiligenberg
authors.forename: René
authors.initials: R
authors.lastname: Lutter
authors.forename: Dasja
authors.initials: D
authors.lastname: Pajkrt
authors.forename: Karin
authors.initials: K
authors.lastname: Adams
authors.forename: Henry
authors.initials: H
authors.lastname: De Vries
authors.forename: Titia
authors.initials: T
authors.lastname: Heijman
authors.forename: Maarten F
authors.initials: MF
authors.lastname: Schim van der Loeff
authors.forename: Suzanne
authors.initials: S
authors.lastname: Geerlings
mesh_terms: D000328:Adult; D002690:Chlamydia Infections / Q000276:immunology* / Q000473:pathology*; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D016207:Cytokines / Q000378:metabolism*; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000276:immunology* / Q000473:pathology*; D018451:Homosexuality, Male; D006801:Humans; D007413:Intestinal Mucosa / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology; D011349:Proctitis / Q000276:immunology* / Q000473:pathology*
chemical_list: D016207:Cytokines
references.citation: Infect Immun. 2011 Nov;79(11):4425-37
references.pmid: 21911470
references.citation: Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):947-52
references.pmid: 10988111
references.citation: Sex Transm Dis. 2008 Nov;35(11):946-59
references.pmid: 18685546
references.citation: J Clin Microbiol. 2009 Jun;47(6):1824-9
references.pmid: 19357201
references.citation: J Infect Dis. 1995 Jul;172(1):186-91
references.pmid: 7797909
references.citation: J Infect Dis. 2005 Jan 1;191(1):20-4
references.pmid: 15592998
references.citation: AIDS. 2002 Jan 25;16(2):219-25
references.pmid: 11807306
references.citation: AIDS Patient Care STDS. 2008 Dec;22(12):947-54
references.pmid: 19072101
references.citation: Am Rev Respir Dis. 1992 Aug;146(2):389-95
references.pmid: 1489129
references.citation: Clin Infect Dis. 2005 Jul 1;41(1):67-74
references.pmid: 15937765
references.citation: Sex Transm Dis. 2007 Jul;34(7):508-12
references.pmid: 17179775
references.citation: J Interferon Cytokine Res. 2010 May;30(5):299-310
references.pmid: 20187769
references.citation: J Inflamm (Lond). 2011 May 03;8:11
references.pmid: 21539730
references.citation: FEMS Immunol Med Microbiol. 2007 Mar;49(2):280-7
references.pmid: 17328762
references.citation: J Reprod Immunol. 2008 Jan;77(1):32-40
references.pmid: 17395270
references.citation: Sex Transm Dis. 2012 Jan;39(1):8-15
references.pmid: 22183837
references.citation: Exp Mol Pathol. 2009 Feb;86(1):65-8
references.pmid: 19010320
references.citation: Microbes Infect. 2006 Jan;8(1):16-26
references.pmid: 16289001
references.citation: Clin Chim Acta. 1987 Jun 15;165(2-3):277-88
references.pmid: 2443279
references.citation: Sex Transm Dis. 2000 May;27(5):243-8
references.pmid: 10821594
references.citation: Infect Immun. 2001 Nov;69(11):7178-81
references.pmid: 11598098
references.citation: Hum Reprod Update. 1999 Sep-Oct;5(5):433-47
references.pmid: 10582782
references.citation: J Clin Invest. 1997 Jan 1;99(1):77-87
references.pmid: 9011579
references.citation: Anesthesiology. 2008 Jan;108(1):46-54
references.pmid: 18156881
references.citation: Lancet. 1997 Jun 28;349(9069):1868-73
references.pmid: 9217758
references.citation: Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1519-27
references.pmid: 7952610
references.citation: Microb Pathog. 2003 Feb;34(2):57-63
references.pmid: 12623273
references.citation: Sex Transm Infect. 2009 Jun;85(3):176-9
references.pmid: 19176570
references.citation: J Med Microbiol. 2007 Aug;56(Pt 8):1025-1032
references.pmid: 17644708